---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-048734"
form_type: "8-K"
ticker: "PVCT"
cik: "0000315545"
company_name: "PROVECTUS BIOPHARMACEUTICALS, INC."
filed_at: "2024-12-05T23:59:59+00:00"
generated_at: "2026-05-29T07:37:42.921659+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Provectus grants ~49.5M stock options to CEO, President, CFO, CTO, directors; CFO salary raised to $200K

## Summary
- CEO Ed Pershing receives 25,470,215 options (grant date value $3,081,896) at $0.2862 exercise price.
- President Dominic Rodrigues receives 16,146,600 options ($1,953,739); CFO Heather Raines receives 4,197,890 options ($507,945).
- CFO base salary increased from $125,000 to $200,000 effective Dec 1, 2024; new employment agreement includes change-in-control provisions.
- Options vest in three equal annual installments for officers; independent directors’ options vest immediately.
- All option grants approved by Board on Nov 18, finalized Dec 2, 2024.

## SEC filing metadata
- accession: 0001493152-24-048734
- form_type: 8-K
- ticker: PVCT
- cik: 0000315545
- company_name: PROVECTUS BIOPHARMACEUTICALS, INC.
- filed_at: 2024-12-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/315545/000149315224048734/0001493152-24-048734-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/315545/000149315224048734/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-048734
- JSON: https://secwatch.observer/filing/0001493152-24-048734.json
- Plain text: https://secwatch.observer/filing/0001493152-24-048734.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.